Press Release

Rod Hunter Joins PhRMA as Senior VP, Int'l Advocacy

PhRMA May 9, 2011

Washington, D.C. (May 9, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Rod Hunter has been named Senior Vice President of International Advocacy, effective June 10, 2011. Hunter will report to Executive Vice President of Advocacy Chip Davis.

In his new role, Hunter will be responsible for leading and overseeing PhRMA’s international advocacy functions. He comes to PhRMA from IBM, where he served as Vice President, Governmental Programs, Europe.

“We are thrilled to have someone of Rod’s caliber join PhRMA’s integrated advocacy team,” Davis said. “With his broad international trade experience in both the private and public sectors, Rod brings to bear a keen understanding of the complex policies and market dynamics inherent to an increasingly global economy. As we continue our work to advance sound policies that recognize the value of medical innovation and ensure patient access to medicines throughout the world, Rod’s leadership will be a tremendous asset.”

“This is a great opportunity to join PhRMA at a time when innovation and globalization are spreading prosperity and changing the way health care is delivered around the world,” Hunter said. “The biopharmaceutical industry has a critical role to play in advancing medical innovation and improving the quality of life for people around the world.”

Prior to heading up IBM’s governmental programs in Europe, Hunter served in senior roles in the U.S. government and as a partner of an international law firm. During his government service, Hunter served as Special Assistant to the President and Senior Director of the White House’s National Security Council under President George W. Bush, where he coordinated the Administration’s international economic agenda, including trade, intellectual property, investment, energy and environmental policies. Before joining the NSC, he served as Special Counsel in the Office of the U.S. Trade Representative.

Prior to 2001, Hunter was a Brussels-based partner with Hunton & Williams, and led the firm’s European regulatory practice. Earlier in his career, he served as an assistant to U.S. Senator John Warner, and as a judicial clerk for Judge Boyce Martin on the U.S. Sixth Circuit Court of Appeals and Australian Chief Justice Sir Anthony Mason. He received a B.A. from Hampden-Sydney College and a J.D. from the University of Virginia.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.4 billion in 2010 in discovering and developing new medicines. Industry-wide research and investment reached a record $67.4 billion in 2010.

Find PhRMA Online:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on ensuring the flow of medicines during public health emergencies, visit